SCHEMBL19239495

SCHEMBL19239495

CCN1C(=O)c2cc(Br)c3c4c(Br)cc5c6c(cc(Br)c(c7c(Br)cc(c2c37)C1=O)c64)C(=O)N(CC)C5=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 5/20 0.51
POLB P06746 1/20 0.41
ALDH1A1 P00352 5/20 0.39
LMNA P02545 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
USP2 O75604 1/20 0.39
ATM Q13315 1/20 0.39
KEAP1 Q14145 1/20 0.39
NFE2L2 Q16236 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HPGD P15428 1/20 0.39
CASP1 P29466 1/20 0.39
MPI P34949 1/20 0.39
CACNA1B Q00975 1/20 0.39
APBA1 Q02410 1/20 0.39
CLTC Q00610 1/20 0.37
MAPT P10636 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16691732 0.89 CYP1B1 (0.43) CYP1B1POLBALDH1A1LMNAKDM4E
SCHEMBL12744274 0.85 CYP1B1 (0.56) CYP1B1POLBALDH1A1LMNAKDM4E
SCHEMBL128105 0.85 CYP1B1 (0.55) CYP1B1POLBALDH1A1LMNAKDM4E
SCHEMBL10261652 0.83 CYP1B1 (0.57) CYP1B1POLBALDH1A1LMNAKDM4E
SCHEMBL127891 0.83 CYP1B1 (0.56) CYP1B1POLBALDH1A1LMNAKDM4E
SCHEMBL24383876 0.80 CYP1B1 (0.35) CYP1B1TERT
SCHEMBL12744263 0.78 APP (0.40) POLBALDH1A1KDM4EMEN1KMT2A
SCHEMBL12711546 0.77 CYP1B1 (0.46) CYP1B1POLBALDH1A1LMNAKDM4E
SCHEMBL13784281 0.77 CYP1B1 (0.46) CYP1B1POLBALDH1A1LMNAKDM4E
SCHEMBL12744276 0.77 ALDH1A1 (0.54) CYP1B1POLBALDH1A1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170250347-A1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM BASF SE (DE) 2017-08-31 US disclosed
US-20170237005-A1 PROCESS FOR PREPARING A CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL BASF SE (DE) 2017-08-17 US disclosed
US-20150307465-A1 Iminothiadiazine Dioxide Compounds as BACE Inhibitors, Compositions and Their Use MERCK SHARP & DOHME CORP. (US) 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307465-A1 Iminothiadiazine Dioxide Compounds as BACE Inhibitors, Compositions and Their Use BACE1, BACE2, APP CYP1B1 51/4885POLB 762/4885ALDH1A1 752/4885
US-20170250347-A1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING A LIQUID MEDIUM CRY1, NEFM, OR10J3 CYP1B1 4419/4885POLB 1747/4885ALDH1A1 4298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.